Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Bacil Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524516

₹12.00

up-down-arrow ₹0.57 (4.99%)

As on 28-Aug-2026IST

Market cap

info icon

₹17 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

26.2

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 69.33 78.90 68.20 7.09 8.93
Net Profit -102.58 -102.39 -56.02 100.77 35.40
EPS -102.59 -102.40 -68.32 65.94 25.19
Book Value -- -- 1,801.64 165.20 70.99
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info ----------
Net Margin info ----204.98----
Return on equity info -9.21-126.982.573.19-11.38
Return on Capital info -3.41-59.71--3.03-4.80
Return on Assets info -3.85-33.542.483.01-5.18
Debt to Equity (x) info ----0.000.010.08

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
3.03
-4.80
-8.45
-273.27
Peer Median
--
14.72
18.85
11.60
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

2.57

Lower than Peers by 8.29

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
2.57
3.19
-11.38
-19.42
-575.48
Peer Median
10.86
11.67
14.92
11.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

2.48

Lower than Peers by 4.26

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
2.48
3.01
-5.18
-9.37
-150.07
Peer Median
6.74
7.86
9.06
6.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

204.98

Higher than Peers by 196.12

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
204.98
61.11
-45.29
-88.92
-6,704.78
Peer Median
8.86
9.33
8.49
10.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

68.20

Higher than Peers by 50.96

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
68.20
-34.36
12.14
94.51
-1,167.86
Peer Median
17.24
24.15
28.00
-3.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-56.02

Lower than Peers by 72.87

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
-56.02
783.93
42.00
97.36
-1,513.41
Peer Median
16.85
30.29
36.51
-0.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-68.32

Lower than Peers by 78.91

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
-68.32
402.29
42.02
97.36
-1,513.29
Peer Median
10.60
24.50
--
-6.82
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
4,204.55
24.59
-21.28
-22.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
0.01
0.08
0.02
0.03
Peer Median
0.04
0.23
0.20
0.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
0.01
0.08
0.02
0.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.68

Lower than Peers by 1.04

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
0.68
17.21
0.46
8.20
6.69
Peer Median
1.72
1.79
1.96
2.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.68

Lower than Peers by 0.50

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
0.68
17.21
0.46
8.20
6.69
Peer Median
1.17
1.47
1.44
1.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
--
-83.43
-66.93
-4,517.88
Peer Median
7.86
9.42
8.58
15.41
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
--
--
--
--
Peer Median
0.67
0.75
0.77
0.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

26.18

Lower than Peers by 13.58

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
26.18
140.14
--
--
--
Peer Median
39.76
39.70
33.48
37.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.68

Lower than Peers by 3.53

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
0.68
2.28
14.96
6.98
5.75
Peer Median
4.21
3.72
4.21
3.22
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
--
--
--
--
--
Peer Median
0.10
0.16
0.21
0.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

102.81

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
102.81
132.15
-154.07
-32.95
-0.82
Peer Median
--
30.23
29.90
28.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

17

Lower than Peers by 7,366

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Bacil Pharma
17
--
--
--
--
Peer Median
7,384
4,851
2,099
15,272
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...